PURE Bioscience (PURE) Underwriters Exercise Full Over--Allotment in Recent Offering
Tweet Send to a FriendGet Alerts PURE Hot Sheet
Trade PURE Now!
PURE Bioscience, Inc. (Nasdaq: PURE) announced the exercise of the over-allotment option granted to the underwriters to purchase 557,615 additional common shares, at a public offering price of $1.10 per share, in connection with its previously announced underwritten public offering of 3,784,000 shares of common stock, bringing total gross proceeds from the offering to $4,775,776, before deducting the underwriting discount and other estimated offering expenses.
Aegis Capital Corp. is acting as sole book-running manager for this offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Aegis Capital Corp. is acting as sole book-running manager for this offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- TCP Capital (TCPC) Prices Upsized 4.5M Common Stock Offering
- Wesco Aircraft (WAIR) Commences 15M Common Stock Offering for Shareholder
- Regeneron (REGN) and Genentech Strike Deal on Worldwide EYLEA Sales
Create E-mail Alert Related Categories
Corporate News, Equity Offerings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
